NU
Nu Skin
NUS · NYSE
$4.58 -0.54% (-$0.03)
1M -3.38%
Market Cap $223.8M
P/E Ratio -
Div. Yield 5.21%
ROE 29.42%
Bulios Fair Price
$5.86
28.1% upside
Current Price
$4.58
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NUS is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
93 /100
Cheap EV/EBITDA 7.58x
P/S 0.16x
P/B 0.41x
Growth
32 /100
Declining EPS growth 15.39%
Rev. growth 12.61%
FCF growth 2.08%
Profitability
22 /100
Weak Gross margin 69.19%
Net margin 15.73%
Op. margin 0.62%
Quality
14 /100
Poor ROIC 7.94%
ROE 29.42%
ROA 19.29%
Debt
61 /100
Moderate Debt/Equity 0.49x
Current ratio 1.98x
Int. coverage -0.68x
Stability
50 /100
Moderate Beta 0.96x
Rev. volatility 1.45%
EPS volatility 1,103.31%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NUS
Online
Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Ryan S. Napierski
Employees
2,800
Headquarters
Provo
Upcoming events
05 NOV
Earnings
Upcoming earnings report